If they'd bought every share since the previous takeover closed, then add in the turncoats' shares they're at around 78%.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025